Ignite Creation Date:
2024-05-06 @ 1:17 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03979131
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-26
First Post:
2019-06-06
Brief Title:
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer GC or Gastroesophageal Junction Cancer GEJC
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stomach Neoplasms |
| Gastroesophageal Junction Adenocarcinoma |
Keywords: